FDA officials: Firms with strong quality cultures more resilient to data integrity problems
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionClinical TrialsGlobalNorth AmericaPharmaceuticalsPreclinical studyRegulatory NewsJoanne S. EglovitchAudit/inspectionClinical TrialsGlobalNorth AmericaPharmaceuticalsPreclinical study